Calretinin (CALB2) is a member of the EF-hand family of Ca(2+)-binding proteins and is expressed in a majority of poorly differentiated colon carcinoma and additionally in mesothelioma of the epithelioid and mixed type. Calretinin (CALB2) is a diagnostic marker for epithelioid mesothelioma. It is also a prognostic marker since patients with tumors expressing high calretinin levels have better overall survival. Silencing of calretinin decreases the viability of epithelioid mesothelioma cells. The calcium-binding protein calretinin (CALB2) is currently considered the most sensitive and specific marker for the diagnosis of malignant mesothelioma (MM). Calretinin (CALB2) is a diagnostic and prognostic marker in malignant pleural mesothelioma (MPM).
- Kresoja-Rakic J, et al. (2016) Identification of cis- and trans-acting elements regulating calretinin expression in mesothelioma cells. Oncotarget 7 (16): 21272-21286.
- Häner K, et al. (2010) A bipartite butyrate-responsive element in the human calretinin (calb2) promoter acts as a repressor in colon carcinoma cells but not in mesothelioma cells. J Cell Biochem 109 (3): 519-531.
- Blum W, et al. (2018) Regulation of calretinin in malignant mesothelioma is mediated by septin 7 binding to the calb2 promoter. BMC Cancer 18 (1): 475.